Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity
- PMID: 33795718
- PMCID: PMC8016996
- DOI: 10.1038/s41598-021-86471-0
Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity
Abstract
The 2019 novel coronavirus pandemic caused by SARS-CoV-2 remains a serious health threat to humans and there is an urgent need to develop therapeutics against this deadly virus. Recent scientific evidences have suggested that the main protease (Mpro) enzyme in SARS-CoV-2 can be an ideal drug target due to its crucial role in the viral replication and transcription processes. Therefore, there are ongoing research efforts to identify drug candidates against SARS-CoV-2 Mpro that resulted in hundreds of X-ray crystal structures of ligand-bound Mpro complexes in the Protein Data Bank (PDB) describing the interactions of different fragment chemotypes within different sites of the Mpro. In this work, we performed rigorous molecular dynamics (MD) simulation of 62 reversible ligand-Mpro complexes in the PDB to gain mechanistic insights about their interactions at the atomic level. Using a total of over 3 µs long MD trajectories, we characterized different pockets in the apo Mpro structure, and analyzed the dynamic interactions and binding affinity of ligands within those pockets. Our results identified the key residues that stabilize the ligands in the catalytic sites and other pockets of Mpro. Our analyses unraveled the role of a lateral pocket in the catalytic site in Mpro that is critical for enhancing the ligand binding to the enzyme. We also highlighted the important contribution from HIS163 in the lateral pocket towards ligand binding and affinity against Mpro through computational mutation analyses. Further, we revealed the effects of explicit water molecules and Mpro dimerization in the ligand association with the target. Thus, comprehensive molecular-level insights gained from this work can be useful to identify or design potent small molecule inhibitors against SARS-CoV-2 Mpro.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.Phys Chem Chem Phys. 2021 Mar 21;23(11):6746-6757. doi: 10.1039/d1cp00266j. Epub 2021 Mar 12. Phys Chem Chem Phys. 2021. PMID: 33711090
-
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.Int J Mol Sci. 2021 Aug 30;22(17):9431. doi: 10.3390/ijms22179431. Int J Mol Sci. 2021. PMID: 34502340 Free PMC article.
-
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors.Molecules. 2021 Apr 5;26(7):2082. doi: 10.3390/molecules26072082. Molecules. 2021. PMID: 33916461 Free PMC article.
-
Artificial intelligence in the prediction of protein-ligand interactions: recent advances and future directions.Brief Bioinform. 2022 Jan 17;23(1):bbab476. doi: 10.1093/bib/bbab476. Brief Bioinform. 2022. PMID: 34849575 Free PMC article. Review.
-
The Three-Dimensional Reference Interaction Site Model Approach as a Promising Tool for Studying Hydrated Viruses and Their Complexes with Ligands.Int J Mol Sci. 2024 Mar 26;25(7):3697. doi: 10.3390/ijms25073697. Int J Mol Sci. 2024. PMID: 38612508 Free PMC article. Review.
Cited by
-
Multi-ligand molecular docking, simulation, free energy calculations and wavelet analysis of the synergistic effects between natural compounds baicalein and cubebin for the inhibition of the main protease of SARS-CoV-2.J Mol Liq. 2023 Mar 15;374:121253. doi: 10.1016/j.molliq.2023.121253. Epub 2023 Jan 16. J Mol Liq. 2023. PMID: 36694691 Free PMC article.
-
Virus structure and structure-based antivirals.Curr Opin Virol. 2021 Dec;51:16-24. doi: 10.1016/j.coviro.2021.09.005. Epub 2021 Sep 24. Curr Opin Virol. 2021. PMID: 34564030 Free PMC article. Review.
-
SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.Comput Biol Med. 2023 Feb;153:106449. doi: 10.1016/j.compbiomed.2022.106449. Epub 2022 Dec 23. Comput Biol Med. 2023. PMID: 36586228 Free PMC article.
-
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease.Nat Commun. 2023 Sep 12;14(1):5625. doi: 10.1038/s41467-023-40023-4. Nat Commun. 2023. PMID: 37699927 Free PMC article.
-
Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies.Molecules. 2024 Feb 25;29(5):998. doi: 10.3390/molecules29050998. Molecules. 2024. PMID: 38474509 Free PMC article.
References
-
- WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
